search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
FRANK J. MILNE STATE-OF-THE-ART LECTURE


centration can be administered intravenously to hy- perlipemic equines that are either hypoglycemic, normoglycemic, or have only mild hyperglycemia. Exogenous insulin therapy may be required if the horse/pony is hyperglycemic. Although hyperli- pemic equines may have an inherent decrease in insulin sensitivity, exogenous insulin can decrease hyperglycemia, inhibit lipolysis and improve cellu- lar energy balance. However, there are no con- trolled studies to provide evidence of efficacy of insulin in treating equine hyperlipemia, nor is there good information on the dose, route, and form of insulin to use although there are individual reports on the use of insulin.177,183 The easiest and gener- ally safest method of administering insulin might be to use 0.10–0.15 IU/kg of an intermediate or long- acting suspension administered subcutaneously ev- ery 12 or 24 hours, respectively. For severe hyperglycemia, a short-acting regular insulin will offer a quicker response and dosage can be quickly adjusted as needed with glucose monitoring. A starting dose for regular insulin that I have used is 0.05–0.1 IU/kg/h as a constant rate infusion (CRI) or intramuscularly every 4–8 hours. When insulin therapy is used, blood glucose and serum potassium must be closely monitored. Intravenous or oral flu- ids are also important in correcting prerenal azotemia, which might decrease LPL activity re- quired to hydrolyze circulating triglycerides. I would recommend oral or slow intravenous admin- istration of B-vitamins daily. Although l-carnitine supplementation is known to affect -oxidation and energy metabolism and it would be of interest (and I have used it in treatment of hyperlipemia) as a potential treatment for hyperlipemia/hepatic lipido- sis, the feeding of dietary l-carnitine supplementa- tion (2 g twice daily) had no effect on plasma FFAs and triglyceride concentrations in healthy ponies.196 Additional studies on l-carnitine in ponies with hyper- lipemia would be of interest. Heparin therapy is generally not recommended


given that LPL may already be maximally activated in equine hyperlipemia184 and, with severe fatty liver, PT and PTT are often prolonged.184,190 I think I made that mistake once of giving too much heparin to a pony with hyperlipemia as the pony developed a severe hemorrhagic crisis. The mortality rate from hyperlipemia and hepatic lipidosis reported in one case series is approximately 50% but the prognosis is variable, depending on the successful and prompt correction of the predisposing cause(s) and on the ability to supply adequate nu- tritional support (enteral or parenteral or both).183 Prognosis should not be based upon the level of triglycerides in the serum or upon liver enzyme el- evations. For example, one miniature horse mare with masseter myopathy (and no detectable sele- nium in her whole blood) had lipemia and a plasma triglyceride concentration of 1926 mg/dL. Follow- ing 2 days of enteral feeding, selenium treatment and intravenous fluids with dextrose, the horse had


88 2015  Vol. 61  AAEP PROCEEDINGS


a triglyceride concentration of 120 mg/dL, with marked improvement in liver function tests and clinical signs. The horse was able to eat on her own on day 4. Hyperlipemic horses with Cushing’s dis- ease that are receiving pergolide treatment in addi- tion to attention to general health care generally have a good prognosis. The prevention of hepatic lipidosis revolves


around identifying at-risk equines, especially preg- nant or lactating pony mares, obese or geriatric po- nies and donkeys, and miniature equines of all ages with diarrhea and other predisposing disorders. Donkeys that have any change in their social status, such as loss of a companion, should be considered at high risk for disease. Providing adequate caloric intake is important in late-pregnant and early-lac- tation mares. As a preventive, fat could be fed to increase caloric density and feeding fat to healthy ponies increases lipoprotein lipase and decreases circulating triglycerides.197 This would not be rec- ommended in at-risk equines that already have hy- perlipidemia. Performing routine body condition scoring and periodic sampling of at-risk equines for triglycerides and free fatty acids could be helpful in identifying metabolic abnormalities before the onset of clinical signs. Proper maintenance health care and husbandry are of utmost importance in at-risk equines. Testing for Cushing’s disease should be instituted in all older at-risk animals.


6. Vascular, Genetic and Miscellaneous Causes of Liver Failure


Hepatic disorders of vascular or genetic origin that result in severe central nervous system signs (he- patic encephalopathy or HE) include congenital por- tosystemic shunts (PSS), a suspected ammonia metabolism defect in Morgan weanlings198–200 and portal vein thrombosis. Additional miscellaneous causes of liver disease or failure include umbilical vein abscesses, liver lobe torsion, a congenital defi- ciency in bilirubin uridine diphosphate glucuronyl- transferase activity, and primary and secondary hepatic neoplasias.


Portosystemic Shunts


PSSs are not common in foals and, when present, are often not detected until the foal is 6 to 12 weeks of age.198,201–203 This relatively late clinical detec- tion could be because hindgut development in young foals is necessary to produce enough enteric ammo- nia to cause sufficient elevations in blood ammonia. We have also noticed that young calves with PSS do not generally exhibit clinical signs until they are ruminants.198,204 The diagnosis of PSS is made af- ter looking at the patient’s age, clinical signs of HE with marked elevation in blood ammonia and bile acids and normal serum hepatic enzymes. The signs of HE in foals with PSS are variable and in- clude lethargy, disorientation, compulsive circling, ptyalism, seizures, central blindness, walking through fences and so on. Blood ammonia can be


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170  |  Page 171  |  Page 172  |  Page 173  |  Page 174  |  Page 175  |  Page 176  |  Page 177  |  Page 178  |  Page 179  |  Page 180  |  Page 181  |  Page 182  |  Page 183  |  Page 184  |  Page 185  |  Page 186  |  Page 187  |  Page 188  |  Page 189  |  Page 190  |  Page 191  |  Page 192  |  Page 193  |  Page 194  |  Page 195  |  Page 196  |  Page 197  |  Page 198  |  Page 199  |  Page 200  |  Page 201  |  Page 202  |  Page 203  |  Page 204  |  Page 205  |  Page 206  |  Page 207  |  Page 208  |  Page 209  |  Page 210  |  Page 211  |  Page 212  |  Page 213  |  Page 214  |  Page 215  |  Page 216  |  Page 217  |  Page 218  |  Page 219  |  Page 220  |  Page 221  |  Page 222  |  Page 223  |  Page 224  |  Page 225  |  Page 226  |  Page 227  |  Page 228  |  Page 229  |  Page 230  |  Page 231  |  Page 232  |  Page 233  |  Page 234  |  Page 235  |  Page 236  |  Page 237  |  Page 238  |  Page 239  |  Page 240  |  Page 241  |  Page 242  |  Page 243  |  Page 244  |  Page 245  |  Page 246  |  Page 247  |  Page 248  |  Page 249  |  Page 250  |  Page 251  |  Page 252  |  Page 253  |  Page 254  |  Page 255  |  Page 256  |  Page 257  |  Page 258  |  Page 259  |  Page 260  |  Page 261  |  Page 262  |  Page 263  |  Page 264  |  Page 265  |  Page 266  |  Page 267  |  Page 268  |  Page 269  |  Page 270  |  Page 271  |  Page 272  |  Page 273  |  Page 274  |  Page 275  |  Page 276  |  Page 277  |  Page 278  |  Page 279  |  Page 280  |  Page 281  |  Page 282  |  Page 283  |  Page 284  |  Page 285  |  Page 286  |  Page 287  |  Page 288  |  Page 289  |  Page 290  |  Page 291  |  Page 292  |  Page 293  |  Page 294  |  Page 295  |  Page 296  |  Page 297  |  Page 298  |  Page 299  |  Page 300  |  Page 301  |  Page 302  |  Page 303  |  Page 304  |  Page 305  |  Page 306  |  Page 307  |  Page 308  |  Page 309  |  Page 310  |  Page 311  |  Page 312  |  Page 313  |  Page 314  |  Page 315  |  Page 316  |  Page 317  |  Page 318  |  Page 319  |  Page 320  |  Page 321  |  Page 322  |  Page 323  |  Page 324  |  Page 325  |  Page 326  |  Page 327  |  Page 328  |  Page 329  |  Page 330  |  Page 331  |  Page 332  |  Page 333  |  Page 334  |  Page 335  |  Page 336  |  Page 337  |  Page 338  |  Page 339  |  Page 340  |  Page 341  |  Page 342  |  Page 343  |  Page 344  |  Page 345  |  Page 346  |  Page 347  |  Page 348  |  Page 349  |  Page 350  |  Page 351  |  Page 352  |  Page 353  |  Page 354  |  Page 355  |  Page 356  |  Page 357  |  Page 358  |  Page 359  |  Page 360  |  Page 361  |  Page 362  |  Page 363  |  Page 364  |  Page 365  |  Page 366  |  Page 367  |  Page 368  |  Page 369  |  Page 370  |  Page 371  |  Page 372  |  Page 373  |  Page 374  |  Page 375  |  Page 376  |  Page 377  |  Page 378  |  Page 379  |  Page 380  |  Page 381  |  Page 382  |  Page 383  |  Page 384  |  Page 385  |  Page 386  |  Page 387  |  Page 388  |  Page 389  |  Page 390  |  Page 391  |  Page 392  |  Page 393  |  Page 394  |  Page 395  |  Page 396  |  Page 397  |  Page 398  |  Page 399  |  Page 400  |  Page 401  |  Page 402  |  Page 403  |  Page 404  |  Page 405  |  Page 406  |  Page 407  |  Page 408  |  Page 409  |  Page 410  |  Page 411  |  Page 412  |  Page 413  |  Page 414  |  Page 415  |  Page 416  |  Page 417  |  Page 418  |  Page 419  |  Page 420  |  Page 421  |  Page 422  |  Page 423  |  Page 424  |  Page 425  |  Page 426  |  Page 427  |  Page 428  |  Page 429  |  Page 430  |  Page 431  |  Page 432  |  Page 433  |  Page 434  |  Page 435  |  Page 436  |  Page 437  |  Page 438  |  Page 439  |  Page 440  |  Page 441  |  Page 442  |  Page 443  |  Page 444  |  Page 445  |  Page 446  |  Page 447  |  Page 448  |  Page 449  |  Page 450  |  Page 451  |  Page 452  |  Page 453  |  Page 454  |  Page 455  |  Page 456  |  Page 457  |  Page 458  |  Page 459  |  Page 460  |  Page 461  |  Page 462  |  Page 463  |  Page 464  |  Page 465  |  Page 466  |  Page 467  |  Page 468  |  Page 469  |  Page 470  |  Page 471  |  Page 472  |  Page 473  |  Page 474  |  Page 475  |  Page 476  |  Page 477  |  Page 478  |  Page 479  |  Page 480  |  Page 481  |  Page 482  |  Page 483  |  Page 484  |  Page 485  |  Page 486  |  Page 487  |  Page 488  |  Page 489  |  Page 490  |  Page 491  |  Page 492  |  Page 493  |  Page 494  |  Page 495  |  Page 496  |  Page 497  |  Page 498  |  Page 499  |  Page 500  |  Page 501  |  Page 502  |  Page 503  |  Page 504  |  Page 505  |  Page 506  |  Page 507  |  Page 508  |  Page 509  |  Page 510  |  Page 511  |  Page 512  |  Page 513  |  Page 514  |  Page 515  |  Page 516  |  Page 517  |  Page 518  |  Page 519  |  Page 520  |  Page 521  |  Page 522  |  Page 523  |  Page 524  |  Page 525  |  Page 526  |  Page 527  |  Page 528  |  Page 529  |  Page 530  |  Page 531  |  Page 532  |  Page 533  |  Page 534  |  Page 535  |  Page 536  |  Page 537  |  Page 538  |  Page 539  |  Page 540  |  Page 541  |  Page 542  |  Page 543  |  Page 544  |  Page 545  |  Page 546  |  Page 547  |  Page 548  |  Page 549  |  Page 550  |  Page 551  |  Page 552  |  Page 553  |  Page 554  |  Page 555  |  Page 556  |  Page 557  |  Page 558  |  Page 559  |  Page 560  |  Page 561  |  Page 562  |  Page 563  |  Page 564  |  Page 565  |  Page 566  |  Page 567  |  Page 568  |  Page 569  |  Page 570  |  Page 571  |  Page 572  |  Page 573  |  Page 574  |  Page 575  |  Page 576  |  Page 577  |  Page 578  |  Page 579  |  Page 580  |  Page 581  |  Page 582  |  Page 583  |  Page 584  |  Page 585  |  Page 586  |  Page 587  |  Page 588  |  Page 589  |  Page 590  |  Page 591  |  Page 592  |  Page 593  |  Page 594  |  Page 595  |  Page 596